CORRIGENDUM

In Zuurbier et al, ¹ the published article contains errors in Table 1. The correct table is shown below. The authors confirm all results, conclusions of this article remain unchanged.

TABLE 1.

FAO inhibitors for IRI

Compound	Mechanism/target	Activity in models of MI	Model	Ref
sulfo‐N‐succinimidyl oleate (SSO)	Inhibition of sarcolemmal FAT/CD36	Prevented cardiac dysfunction after ischaemia	Isolated diabetic and control male Wistar rat harts	[161]
CBM‐301940 CBM‐300864	Inhibition of malonyl CoA decarboxylase	Improved cardiac function during and after ischaemia	Isolated rat hearts Pigs in vivo	[162, 163]
Methyl‐GBB	decreased accumulation of long‐chain acylcarnitines	Decreased MI size, improved survival	ligation of LAD, rats Isolated perfused rat hearts	[164]
Trimetazidine	long‐chain 3‐ketoacyl‐CoA thiolase inhibitor AMPK and ERK signalling pathways	Reduced MI size and oxidative stress	in vivo regional ischaemia and reperfusion, mice	[165]
carvedilol	adrenergic receptor blocker; modulator of cardiac AMPK signalling pathway	MI size reduction, improved cardiac functions	ligation of LAD, mice	[166]

Abbreviations: LAD, left anterior descending coronary artery; MI, myocardial infarction.